Network meta-analyses in health technology assessment: an interview with Mario Ouwens

Written by The Evidence Base
Decision science Health technology assessment Interviews ISPOR Methodology

At ISPOR Europe (2–6 November 2019; Copenhagen, Denmark) we spoke with Mario Ouwens (AstraZeneca; Mondal, Sweden) about the use of network meta-analyses, hazard ratios and survival probabilities in health technology assessment. Over the course of the ISPOR Europe (2–6 November 2019; Copenhagen, Denmark) meeting, The Evidence Base® brought you daily video updates, news and plenary round-ups – check out our conference coverage here>> We also had the pleasure of speaking with Mario Ouwens (AstraZeneca; Mondal, Sweden) about utilizing network meta-analyses, hazard ratios and survival probabilities in health technology assessment.

To view this content, please register now for access

It's completely free